BIOMARIN PHARMACEUTICAL INC Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Biomarin Pharmaceutical Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $43.5M, a 10.1% decline year-over-year.
  • Biomarin Pharmaceutical Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $205M, a 2.78% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Share-based Payment Arrangement, Expense for 2023 was $207M, a 5.5% increase from 2022.
  • Biomarin Pharmaceutical Inc annual Share-based Payment Arrangement, Expense for 2022 was $196M, a 0.48% decline from 2021.
  • Biomarin Pharmaceutical Inc annual Share-based Payment Arrangement, Expense for 2021 was $197M, a 3.98% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $207M +$10.8M +5.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 $196M -$955K -0.48% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 $197M +$7.55M +3.98% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $190M +$29.8M +18.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $160M +$11M +7.42% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $149M +$8.56M +6.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $140M +$5.62M +4.18% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $135M +$23.1M +20.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $112M +$25.1M +29.1% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
2014 $86.4M +$22M +34.2% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
2013 $64.4M +$16.4M +34.2% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $48M +$4.15M +9.48% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
2011 $43.8M +$6.33M +16.9% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-26
2010 $37.5M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.